SOURCE: Medpace


March 01, 2011 09:00 ET

Medpace Medical Device (MMD) Announces the Addition of Diane Sahr, RN as Vice President, Clinical Affairs

CINCINNATI, OH--(Marketwire - March 1, 2011) - Medpace, Inc. announced the addition of Diane Sahr, RN as a Vice President, Clinical Affairs for Medpace Medical Device, a wholly owned subsidiary of Medpace based in Minneapolis, MN. Medpace Medical Device conducts global clinical trials for both pre-market approval and post-market outcomes for medical device sponsors worldwide.

Diane Sahr has more than twenty years of clinical research and cost effectiveness research experience and has a unique understanding of healthcare in that she has led evidence-based medicine efforts in all sectors of the healthcare delivery system including hospitals, clinics, payers, and the medical device industry. As a clinical leader, Diane has overseen the design and execution of more than 50 investigational and post-market global clinical trials and has achieved a greater than 90% success in publication of the evidence. Diane has device experience in multiple therapeutic areas including cardiology, neurology, orthopedics and urology.

"Diane's personal passion for strategic trial design as well as her reputation for trial execution, brings unique value to MMD's customers," said Ryan Wilson, General Manager, MMD. "She brings a keen sense of early data interpretation and its relevance when evaluating products in feasibility stages and identifying evidence needs. These skills will be valuable assets for our clients, helping ensure that their trials are a success."

The addition of Diane Sahr, who will provide strategic consulting in the design and implementation of trials, demonstrates a commitment to add depth in medical device expertise for the benefit of its Sponsors. With additional knowledge experts in this sector, Medpace Medical Device and Medpace are poised to bring expertise to the design of medical device clinical trials on a global basis.

Medpace Medical Device (MMD) is a full service medical device CRO in the Minneapolis, Minnesota area. MMD offers trial design, project management, site management, monitoring, biostatistics, regulatory support, and data management for companies with medical devices in the human clinical trial phase. MMD has the ability to conduct medical device clinical trials for small or large sponsors, and for trials in both the US and worldwide.

Visit Medpace Medical Device at:

Medpace is a leading global full-service clinical research organization providing Phase I-IV core development services for drug, biologic, and device programs. With medical and regulatory expertise in multiple therapeutic specialties, Medpace has assembled the industry's most experienced and therapeutically focused teams to execute at every level of the company's operations, providing complete and seamless drug development services. In June 2009 Medpace was rated as the best CRO by U.S. Investigators in the 2009 CenterWatch Site Survey.

Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development -- from program planning and execution to product approval.

With more than 1000 employees and clinical trial experience in over 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide. In addition to Phase II-IV development services, Medpace provides Phase I / IIA clinical services from Medpace Clinical Pharmacology, central laboratory and therapeutically specialized testing from Medpace Reference Laboratories, complete bioanalytical services in all stages of drug development from Medpace Bioanalytical Laboratories, centralized imaging core laboratory management and reading from Imagepace, and medical device development from Medpace Medical Device

Visit the Medpace website at